Paul Peter Rosen

Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer.

José Baselga, Debu Tripathy, John Mendelsohn et al. · Journal of Clinical Oncology · 1996 · 1.4K citations

Medicine, Oncology, Pharmacology +17

Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis

Jeanne A. Petrek, Ruby T. Senie, Margaret Peters et al. · Cancer · 2001 · 683 citations · Full text

Medicine, Oncology, Surgery +16

Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases.

R. J. Cote, Paul Peter Rosen, Martin Lesser et al. · Journal of Clinical Oncology · 1991 · 443 citations

Medicine, Oncology, Pathology +16

Medullary carcinoma of the breast.A clinicopathologic study with 10 year follow-up

Ren L. Ridolfi, Paul Peter Rosen, Abraham Port et al. · Cancer · 1977 · 420 citations

Medicine, Oncology, Pathology +11

Lobular carcinoma in situ of the breast Detailed analysis of 99 patients with average follow-up of 24 years

Paul Peter Rosen, Philip Lieberman, David W. Braun et al. · The American Journal of Surgical Pathology · 1978 · 372 citations

Medicine, Oncology, Surgery +17